How do Sleeping Pills Affect Pain in the Brain?
NCT00414037 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2015-10-26
Summary
If you are age 20-55 years old and have trouble falling or staying asleep, then please contact a UCSD research team to find out how a study drug affects these symptoms and how your brain works. This is a one-week experimental pain research study using a study drug compared to placebo. Your participation will include questionnaires, a physical exam and functional Magnetic Resonance Imaging (fMRI) brain imaging techniques. We will test pain perception by applying brief mild to moderate heat pain to the forearm, and also have you perform simple computer tasks while we image and record brain activity using fMRI.
Conditions
- Primary Insomnia
Interventions
- DRUG
-
Eszopiclone
- DRUG
-
Placebo-treatment
Sponsors & Collaborators
-
Sumitomo Pharma America, Inc.
collaborator INDUSTRY -
University of California, San Diego
lead OTHER
Principal Investigators
-
Martin P Paulus, M.D. · University of California, San Diego
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- United States
Study Locations
More Related Trials
-
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
NCT00177216 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients
NCT00460993 ·Status: COMPLETED ·Phase: PHASE4
-
Ezopiclone Improves the Quality of Overnight Polysomnography
NCT00507117 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients
NCT02455271 ·Status: COMPLETED
-
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
NCT00352144 ·Status: COMPLETED ·Phase: PHASE3
-
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
NCT00283790 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
NCT00368056 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
NCT00324896 ·Status: COMPLETED ·Phase: PHASE3
-
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
NCT00822679 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers
NCT00368160 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
NCT04299490 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
NCT00368030 ·Status: COMPLETED ·Phase: PHASE3
-
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
NCT00235508 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
NCT01207050 ·Status: UNKNOWN ·Phase: PHASE4
-
The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women
NCT00374192 ·Status: COMPLETED ·Phase: NA
-
Testing the Nocturnal Sleep Latency Profile in Primary Insomnia
NCT00167375 ·Status: COMPLETED
-
A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
NCT00722306 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
NCT05525637 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia
NCT00466193 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep Loss and Mechanisms of Impaired Glucose Metabolism
NCT00555750 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants
NCT05651152 ·Status: COMPLETED ·Phase: PHASE1
-
Disturbed Sleep Model Study.
NCT00440323 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02839200 ·Status: COMPLETED ·Phase: PHASE2